Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

BACKGROUND: Among US adults, utilization of pharmacotherapy for attention-deficit hyperactivity disorder (ADHD) has increased more than ninefold since 1995–1996. Potential contraindications to ADHD pharmacotherapy include serious cardiovascular disease (CVD) and, for stimulants, addictions and bipol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairman, Kathleen A., Davis, Lindsay E., Peckham, Alyssa M., Sclar, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825392/
https://www.ncbi.nlm.nih.gov/pubmed/29305714
http://dx.doi.org/10.1007/s40801-017-0129-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825392/
https://www.ncbi.nlm.nih.gov/pubmed/29305714
http://dx.doi.org/10.1007/s40801-017-0129-2

Ejemplares similares